
CAS 1146977-93-6
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produtos.
Atorvastatin Ethyl Ester (ethyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C35H39FN2O5Cor e Forma:White Off-White SolidPeso molecular:586.2843Atorvastatin EP Impurity M (Atorvastatin Ethyl Ester)
CAS:Fórmula:C35H39FN2O5Cor e Forma:White To Off-White SolidPeso molecular:586.70Atorvastatin Ethyl Ester
CAS:Produto ControladoFórmula:C35H39FN2O5Cor e Forma:NeatPeso molecular:586.69Atorvastatin Ethyl Ester
CAS:Produto Controlado<p>Applications Atorvastatin (A791750) impurity.<br>References Kearney, A.S., et al.: Pharm. Res., 10, 1461 (1993); Heinonen, T.M., et al.: Clin. Ther., 18, 853 (1996);<br></p>Fórmula:C35H39FN2O5Cor e Forma:Off White SolidPeso molecular:586.69Atorvastatin ethyl ester
CAS:<p>Atorvastatin ethyl ester is a prodrug of atorvastatin that is used for the treatment of hypercholesterolemia. It inhibits HMG-CoA reductase, which reduces cholesterol production in the liver. The permeation rate of atorvastatin ethyl ester is increased by coadministration with c1-c10 fatty acids, which can be achieved by taking it with food. Atorvastatin ethyl ester has been shown to have antithrombotic and anti-inflammatory effects, which are due to its inhibition of the synthesis of thromboxane A2 and prostaglandin E2. Atorvastatin also inhibits protein synthesis in some cells, such as hepatocytes and neutrophils, but not in others such as fibroblasts or platelets. This may be related to the expression of an enzyme called cytosolic phospholipase A2 (cPLA2).</p>Fórmula:C35H39FN2O5Pureza:Min. 95%Cor e Forma:PowderPeso molecular:586.69 g/molAtorvastatin ethyl ester
CAS:Atorvastatin ethyl ester, a derivative of Atorvastatin, exhibits potent inhibition of 9-cis-RA-induced Gal4 reporter activity.Fórmula:C35H39FN2O5Pureza:98%Cor e Forma:SolidPeso molecular:586.69







